Cat.#: ACPP-1369
| Despition | Parkin Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1787 | Exenatide (AC1787) | 1 mg | inquiry |
| ACPP-1202 | Pin1 Blocking Peptide (AC1202) | 250 µg | inquiry |
| ACPP-1085 | Recombinant Human alpha Internexin Protein (AC1085) | 25 µl | inquiry |
| ACPP-1713 | Human SNCB Protein (AC1713) | 10 µg | inquiry |
| ACPP-1054 | Recombinant Human Neuroglycan C Protein (6×His Tag) (AC1054) | 50 µg | inquiry |
| ACPP-1009 | Recombinant Human TYRO3 Protein (6×His Tag) (AC1009) | 50 µg | inquiry |
| ACPP-1495 | Cofilin Blocking Peptide (AC1495) | 250 µg | inquiry |
| ACPP-1527 | Mouse ANTXR2 Protein (AC1527) | 1 µg | inquiry |
| ACPP-1427 | Human ASMT Protein (AC1427) | 5 µg | inquiry |
| ACPP-1262 | CXCR4 Blocking Peptide (AC1262) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.